Search Blog
Categories
May 2017
M T W T F S S
« Apr    
1234567
891011121314
15161718192021
22232425262728
293031  

Tags

Bexil Corporation Reports 2016 Financial Results and Announces Annual Meeting and Conference Call

By Bexil Corporation

NEW YORK, NY / ACCESSWIRE / May 26, 2017 / Bexil Corporation (OTC PINK: BXLC) today reported its financial results for the year ended December 31, 2016. Bexil recorded net income attributable to Bexil shareholders of $0.95 million, or $0.97 per share, for the year ended December 31, 2016, compared to a net loss attributable to Bexil shareholders of $1.66 million, or $1.69, including $0.6 million, or $0.59 per share income from discontinued operations per share for the year ended December 31, 2015.

The Company’s book value per share attributable to Bexil shareholders at December 31, 2016 was $18.64, based on shareholders’ equity attributable to Bexil shareholders of $18.2 million and 977,168 shares issued and outstanding, share, up 7.8% from $17.29 per share a year earlier.

2017 Annual Meeting of Stockholders

Bexil announced today that its 2017 annual meeting of stockholders will be held at 11 Hanover Square, 12th Floor, New York, New York on June 15, 2017 at 11:30 a.m., local time. Stockholders of record at the close of business on April 17, 2017 are entitled to receive notice of and to vote at the meeting. After the formal business of the meeting is concluded, company executives will make a presentation of financial results and business developments, and respond to questions. To access the annual meeting and presentation by conference call, please dial 1-267-930-4000, Access Code: 509840#.

The Company’s Combined 2017 Proxy Statement and 2016 Annual Report, including audited financial statements, are available on www.Bexil.com.

About Bexil Corporation

Bexil is a holding company engaged through subsidiaries in investment management and securities trading. To learn more about Bexil, including Rule 15c2-11 information, please visit www.Bexil.com.

Safe Harbor Note

This release contains certain “forward-looking statements” made pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. These statements involve known and unknown risks, uncertainties and other factors, many of which are beyond the control of Bexil, which may cause the Company’s actual results to be materially different from those expressed or implied by such statements. Investors should carefully consider the risks, uncertainties and other factors, together with all of the other information included in the Company’s Annual Report, at http://www.bexil.com/cautionary-language.html, and similar information. The forward-looking statements made herein are only made as of the date of this release, and the Company undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.

The Company views book value per share, a non-GAAP financial measure, as an important indicator of financial performance. Presented in conjunction with other financial information, the combined presentation can enhance an investor’s understanding of the Company’s underlying financial condition and results from operations. The definition of book value as presented in this press release is shareholders’ equity attributable to Bexil shareholders divided by currently issued and outstanding shares.

Contact:

Thomas O’Malley
Chief Financial Officer
1-212-785-0900, ext. 267
tomalley@bexil.com
www.Bexil.com

SOURCE: Bexil Corporation

ReleaseID: 464331

Bexil Corporation Announces First Quarter 2017 Financial Results

By Bexil Corporation

NEW YORK, NY / ACCESSWIRE / May 26, 2017 / Bexil Corporation (OTC PINK: BXLC) today reported its financial results for the first quarter ended March 31, 2017. Bexil recorded net income attributable to Bexil shareholders of $0.34 million or $0.35 per share for the three months ended March 31, 2017, compared to net income attributable to Bexil shareholders of $0.26 million, or $0.27 per share, for the three months ended March 31, 2016.

The Company’s book value per share attributable to Bexil shareholders at March 31, 2017 was $20.21, based on shareholders’ equity attributable to Bexil shareholders of $17.9 million and 884,878 shares issued and outstanding.

The Company’s unaudited balance sheet, statements of comprehensive loss, and statements of cash flows as of and for the three months ended March 31, 2017 are appended to the copy of this press release on www.Bexil.com.

About Bexil Corporation

Bexil is a holding company engaged through subsidiaries in investment management and securities trading. To learn more about Bexil, including Rule 15c2-11 information, please visit www.Bexil.com.

Safe Harbor Note

This release contains certain “forward-looking statements” made pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. These statements involve known and unknown risks, uncertainties and other factors, many of which are beyond the control of Bexil, which may cause the Company’s actual results to be materially different from those expressed or implied by such statements. Investors should carefully consider the risks, uncertainties and other factors, together with all of the other information included in the Company’s Annual Report, at http://www.bexil.com/cautionary-language.html, and similar information. The forward-looking statements made herein are only made as of the date of this release, and the Company undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.

The Company views book value per share, a non-GAAP financial measure, as an important indicator of financial performance. Presented in conjunction with other financial information, the combined presentation can enhance an investor’s understanding of the Company’s underlying financial condition and results from operations. The definition of book value as presented in this press release is shareholders’ equity attributable to Bexil shareholders divided by currently issued and outstanding shares.

Contact:

Thomas O’Malley
Chief Financial Officer
1-212-785-0900, ext. 267
tomalley@bexil.com
www.Bexil.com

SOURCE: Bexil Corporation

ReleaseID: 464336

DEADLINE TUESDAY: Lundin Law PC Announces Securities Class Action Lawsuit against Inventure Foods, Inc. and Reminds Investors with Losses to Contact the Firm

By Lundin Law PC

LOS ANGELES, CA / ACCESSWIRE / May 26, 2017 / Lundin Law PC , a shareholder rights firm, announces a class action lawsuit against Inventure Foods, Inc. (“Inventure” or the “Company”) (NASDAQ: SNAK) for possible violations of federal securities laws between March 3, 2016 and March 16, 2017, inclusive (the “Class Period”). Investors, who purchased or otherwise acquired shares during the Class Period, should contact the firm prior to the May 30, 2017 lead plaintiff motion deadline.

To participate in this class action lawsuit, click here.

You can also call Brian Lundin, Esq., of Lundin Law PC, at 888-713-1033, or e-mail him at brian@lundinlawpc.com.

No class has been certified in the above action yet. Until a class is certified, you are not considered represented by an attorney. You may also choose to do nothing and be an absent class member.

According to the Complaint, during the Class Period, Inventure made false and/or misleading statements and/or failed to disclose: that the Company lacked adequate internal controls over accounting and financial reporting; that Inventure’s statements of operations in its fiscal year 2015 results press release contained incorrect figures; and that as a result of the above, the Company’s statements concerning its business, operations, and prospects were false and misleading and/or lacked a reasonable basis. On March 9, 2017, Inventure revealed that it would delay its annual filing on Form 10-K for its fiscal year ended December 31, 2016 and that it expected to file a notification of late filing on Form 12b-25 with the SEC to obtain a 15-day extension of the filing deadline for the Form 10-K. On March 16, 2017, the Company filed a notice with the SEC revealing that it would delay its 2016 fiscal year annual report. The Company also said that it believes its statements of operations contained in the annual report “will differ materially” from those reported for its fourth quarter and fiscal year 2015. Following the release of this news, Inventure’s stock price dropped significantly, which harmed investors according to the Complaint.

Lundin Law PC was created by Brian Lundin, a securities litigator based in Los Angeles dedicated to upholding shareholders’ rights.

This press release may be considered Attorney Advertising in certain jurisdictions under the applicable law and ethics rules.

Contact:

Lundin Law PC
Brian Lundin, Esq.
Telephone: 888-713-1033
Facsimile: 888-713-1125
brian@lundinlawpc.com
http://lundinlawpc.com/

SOURCE: Lundin Law PC

ReleaseID: 464339

IIROC Trade Resumption – Aurora Cannabis Inc.

Vancouver, British Columbia–(Newsfile Corp. – May 26, 2017) – Trading resumes in:

Company:

Aurora Cannabis Inc.

TSX-V Symbol:

ACB

Resumption Time (ET):

16:00

IIROC can make a decision to impose a temporary suspension of trading in a security of a publicly listed company, usually in anticipation of a material news announcement by the company. Trading halts are issued based on the principle that all investors should have the same timely access to important company information. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

– 30 –

For further information: IIROC Inquiries 1-877-442-4322 (Option 3) – Please note that IIROC is not able to provide any additional information regarding a specific trading halt. Information is limited to general enquiries only.

IIROC Trade Resumption – Hunt Mining Corp

Vancouver, British Columbia–(Newsfile Corp. – May 26, 2017) – Trading resumes in:

Company:

Hunt Mining Corp

TSX-V Symbol:

HMX

Resumption Time (ET):

08:00 May 29, 2017

IIROC can make a decision to impose a temporary suspension of trading in a security of a publicly listed company, usually in anticipation of a material news announcement by the company. Trading halts are issued based on the principle that all investors should have the same timely access to important company information. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

– 30 –

For further information: IIROC Inquiries 1-877-442-4322 (Option 3) – Please note that IIROC is not able to provide any additional information regarding a specific trading halt. Information is limited to general enquiries only.

IIROC Trade Resumption – Assure Holdings Corp.

Vancouver, British Columbia–(Newsfile Corp. – May 26, 2017) – Trading resumes in:

Company:

Assure Holdings Corp.

TSX-V Symbol:

IOM

Resumption Time (ET):

08:00 May 29, 2017

IIROC can make a decision to impose a temporary suspension of trading in a security of a publicly listed company, usually in anticipation of a material news announcement by the company. Trading halts are issued based on the principle that all investors should have the same timely access to important company information. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

– 30 –

For further information: IIROC Inquiries 1-877-442-4322 (Option 3) – Please note that IIROC is not able to provide any additional information regarding a specific trading halt. Information is limited to general enquiries only.

IIROC Trade Resumption – Global Daily Fantasy Sports Inc

Vancouver, British Columbia–(Newsfile Corp. – May 26, 2017) – Trading resumes in:

Company:

Global Daily Fantasy Sports Inc

TSX-V Symbol:

DFS

Resumption Time (ET):

15:00

IIROC can make a decision to impose a temporary suspension of trading in a security of a publicly listed company, usually in anticipation of a material news announcement by the company. Trading halts are issued based on the principle that all investors should have the same timely access to important company information. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

– 30 –

For further information: IIROC Inquiries 1-877-442-4322 (Option 3) – Please note that IIROC is not able to provide any additional information regarding a specific trading halt. Information is limited to general enquiries only.

INVO Bioscience to Present at the LD Micro Invitational Investor Conference

By INVO Bioscience, Inc.

Company Will Present on Wednesday, June 7, 2017 at 2:30pm PT (5:30pm ET)

MEDFORD, MA / ACCESSWIRE / May 26, 2017 / INVO Bioscience, Inc. (OTC PINK: IVOB), a medical device company who was granted FDA clearance for the first Intravaginal Culture System, INVOcell™, today announced that management will present at the LD Micro Invitational Conference on Wednesday, June 7, 2017 at 2:30pm PT (5:30pm ET) in Track 3. The conference is being held at the Luxe Hotel in Los Angeles, California.

Management will be available for one-on-one meetings during the Conference. Investors interested in arranging a meeting with management should contact their LD Micro representative or Lytham Partners at (602) 889-9700 or at info@lythampartners.com.

The presentation will be available on the company’s website at https://invobioscience.com/investors/.

“This year, not only do we have a record number of companies making their LD Micro debuts, but a record number of companies presenting for the first time in their company’s history,” stated Chris Lahiji, President of LD Micro. “LD has established itself as the one venue that brings the most influential players from all segments of the market under one roof.”

View INVO Bioscience’s profile here: http://www.ldmicro.com/profile/IVOB

Profiles powered by LD Micro – News Compliments of ACCESSWIRE.

About INVO Bioscience

We are a medical device company focused on creating simplified, lower cost treatments for patients diagnosed with infertility. Our solution, the INVO Procedure, is a disruptive new technology. The INVO Procedure is a revolutionary in vivo method of vaginal incubation that offers patients a more natural and intimate experience. Our lead product, the INVOcell, is a patented medical device used in infertility treatment and is considered an Assisted Reproductive Technology (ART). The INVOcell is the first Intravaginal Culture (IVC) system in the world used for the natural in vivo incubation of eggs and sperm during fertilization and early embryo development, as an alternative to traditional In Vitro Fertilization (IVF) and Intrauterine Insemination (IUI). Our mission is to increase access to care and expand fertility treatment across the globe with a goal to lower the cost of care and increase availability of care. For more information, please visit http://invobioscience.com/.

About LD Micro

LD Micro was founded in 2006 with the sole purpose of being an independent resource in the microcap space. What started out as a newsletter highlighting unique companies has transformed into an event platform hosting several influential conferences annually (Invitational, Summit, and Main Event).

In 2015, LDM launched the first pure microcap index (the LDMi) to exclusively provide intraday information on the entire sector. LD will continue to provide valuable tools for the benefit of everyone in the small and microcap universe.

For those interested in attending, please contact David Scher at david@ldmicro.com or visit www.ldmicro.com for more information.

Safe Harbor Statement

This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The Company invokes the protections of the Private Securities Litigation Reform Act of 1995. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategies, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, as well as statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements. All forward-looking statements involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. Factors that may cause actual results to differ materially from those in the forward-looking statements include those set forth in our filings at www.sec.gov. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.

Investor Relations Contact:
Lytham Partners, LLC
Robert Blum, Joseph Diaz, or Joe Dorame
(602) 889-9700
info@lythampartners.com

Invo Bioscience Contact:
Kathleen Karloff, CEO
(978) 878-9505 ext. 504
kkarloff@invobio.com

SOURCE: INVO Bioscience, Inc.

ReleaseID: 464330

Fairmont Resources Inc. Receives Notice

Vancouver, British Columbia–(Newsfile Corp. – May 26, 2017) – Fairmont Resources Inc. (TSXV: FMR) (“Fairmont or the “Company”) announces that, in connection with its Granitos de Badajoz (“Grabasa”) acquisition, the company’s lawyers in Spain received on May 26, 2017, a resolution stating that the offer to acquire the assets of Grabasa has been terminated by the Court, located in Badajoz, Spain. Fairmont’s lawyers have identified several key points which may be considered legally inaccurate.

On that ground, Fairmont will appeal the court’s ruling on several points. As well, it is a very serious situation that it appears the court ruling was leaked to the media before Fairmont was notified. Fairmont expects to file a complaint in relation to this leak. The leak appears to be malicious and with the intent to damage the reputation of Fairmont with the local community and former employees of Grabasa in Spain.

Fairmont is also pursuing additional options to complete the acquisition of Grabasa and is committed to bringing Grabasa back into production and bringing jobs back to the region.

About Fairmont Resources Inc.

Fairmont Resources Inc. is a rapidly growing industrial mineral and dimensional stone company trading on the Toronto Venture Exchange symbol FMR.

Fairmont’s Quebec properties cover numerous occurrences of high-grade titaniferous magnetite with vanadium, with the Buttercup property having a permit to quarry dense aggregate. Where these occurrences have been tested they have display exceptional uniformity with respect to grade. Fairmont also controls three quartz/quartzite properties, with the Forestville property having independent end user testing confirming the suitability of quartzite from Forestville for Ferro Silicon production. Fairmont is also in the process of acquiring the assets of Granitos de Badajoz (GRABASA) in Spain which includes 23 quarries and a 40,000 square metre granite finishing facility that has produced finished granite installed across Europe.

On behalf of the Board of Directors,

Michael A. Dehn
President and CEO, Fairmont Resources Inc.
Tel: 647-477-2382
michael@fairmontresources.ca
www.fairmontresources.ca

For further information please contact:

Doren Quinton,
President QIS Capital
Tel: 250-377-1182
info@smallcaps.ca
www.smallcaps.ca

Forward-Looking Statements

Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management’s current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. Fairmont cautions that all forward looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond Fairmont’s control. Such factors include, among other things: risks and uncertainties relating to Fairmont’s ability to complete the proposed private placement financing, limited operating history and the need to comply with environmental and governmental regulations. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward looking information. Except as required under applicable securities legislation, Fairmont undertakes no obligation to publicly update or revise forward-looking information.

NEITHER TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

Ely Gold Purchases Nevada Mining Claims

Vancouver, British Columbia–(Newsfile Corp. – May 26, 2017) – Ely Gold & Minerals Inc. (TSXV: ELY) (OTC Pink: ELYGF) (“Ely Gold” or the “Company”) and its wholly owned subsidiary, Nevada Select Royalty, Inc. (“Nevada Select”) are pleased to announce that they have entered into a definitive purchase agreement with Eastfield Resources Ltd (TSX-V: ETF) (“Eastfield“), through their wholly owned U.S subsidiary, Eastfield Resources (USA) Inc., whereby Ely Gold has acquired an interest in the 18 patented mining claims, located in Esmeralda and Nye Counties, Nevada. (the “Transaction“) The closing of the Transaction is subject to further due diligence by Ely Gold and approval of the TSX-V.

The Tonopah-Hughes claims consists of eleven (11) patented lode claims and seven (7) fractional patented lode claims. (the “Property“). Ten of the claims are subject to an underlying net smelters royalty of two percent (2%) and the remaining eight (8) claims are subject to an underlying net smelters royalty of three percent (3%). Pursuant to the terms of the Transaction, Nevada Select will purchase Eastfield’s interest in and to the Property by making a single cash payment of CAN$50,000 and by Ely Gold issuing of 300,000 of its common shares to Eastfield.

Trey Wasser, President and CEO of Ely Gold commented on the Transaction, “The consolidation of these patented claims with the unpatented claims currently held in the Nevada Select portfolio, creates another valuable project in an important historic mining district in Nevada”

Stephen Kenwood, P. Geo, is director of the Company and a Qualified Person as defined by NI 43-101. Mr. Kenwood has reviewed and approved the technical information in this press release.

About Ely Gold

Ely Gold is focused on developing recurring cash flow streams through the acquisition, consolidation, enhancement, and resale of highly prospective, un-encumbered North American precious metals properties. Ely’s property development efforts maximize each property’s potential for acquisition, while reserving significant royalty interests. Additional information about Ely Gold is available at the Company’s website, at www.elygoldinc.com.

On Behalf of the Board of Directors

Signed “Trey Wasser”
Trey Wasser, President & CEO

For further information, please contact:
trey@elygoldinc.com

972-803-3087

ir@elygoldinc.com
604-488-1104

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. This news release may contain forward-looking statements including but not limited to comments regarding the due diligence and TSX Venture Exchange conditions to the closing of the Transaction, etc. Forward-looking statements address future events and conditions and therefore, involve inherent risks and uncertainties. Actual results may differ materially from those currently anticipated in such statements.